KetoSwiss is a Swiss biotechnology company located in Basel, that develops and clinically tests a novel nutraceutical/medical food for the dietary preventive therapy of higher-frequency migraines and possibly other related neurological diseases characterized by a metabolic dysfunction (such as Alzheimer's disease). The lead product’s active substance is an endogenous metabolite – a Ketone body, that can be used by the human brain as an alternative source of fuel to glucose, when glucose utilization or transport is compromised.